Issue 4, 2013

Facile solid-phase synthesis of a highly stable poly(ethylene glycol)–oligonucleotide conjugate

Abstract

A novel solid-phase synthesis method for poly(ethylene glycol) (PEG)–oligonucleotide conjugates was developed to increase the stability of therapeutic oligonucleotides such as antisense oligonucleotides and siRNA. A prepared solid phase was pre-installed with PEG to provide oligonucleotides modified with PEG at the 3′ terminus. Compared with the conventional liquid-phase synthesis method, the developed solid-phase method is simple and reproducible. PEGylation at the 3′ terminus was confirmed to stabilize not only DNA but also RNA more than PEGylation at the 5′ terminus, which has been widely used so far.

Graphical abstract: Facile solid-phase synthesis of a highly stable poly(ethylene glycol)–oligonucleotide conjugate

Article information

Article type
Paper
Submitted
28 Aug 2012
Accepted
08 Nov 2012
First published
09 Nov 2012

J. Mater. Chem. B, 2013,1, 529-535

Facile solid-phase synthesis of a highly stable poly(ethylene glycol)–oligonucleotide conjugate

Y. Ikeda, H. Kawasaki, S. Ichinohe and Y. Nagasaki, J. Mater. Chem. B, 2013, 1, 529 DOI: 10.1039/C2TB00031H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements